Perioperative monitoring of thromboelastograph on hemostasis and therapy for cyanotic infants undergoing complex cardiac surgery

Artificial Organs

Volumn 33, Issue 11, 2009, Pages 909-914

  Cui, Yongli ^a   Hei, Feilong ^a   Long, Cun ^a   Feng, Zhengyi ^a   Zhao, Ju ^a   Yan, Fuxia ^a   Wang, Yuhong ^a   Liu, Jinping ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Cardiopulmonary bypass; Complex congenital heart disease; Cyanotic; Hematocrit; Hemostasis

Indexed keywords

CARDIOLOGY; CARDIOVASCULAR SURGERY; DISEASES; HEART;

ANESTHESIA INDUCTION; CARDIAC-SURGERY; CARDIOPULMONARY BYPASS; COMPLEX CONGENITAL HEART DISEASE; CONGENITAL HEART DISEASE; CYANOTIC; HAEMATOCRIT; HAEMOSTASIS; NEUTRALISATION; NORMAL FUNCTION;

DISEASE CONTROL;

FIBRINOGEN; NEUTRALIZING ANTIBODY;

ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CYANOSIS; DRUG EFFECT; HEART SURGERY; HEMATOCRIT; HEMOSTASIS; HUMAN; PERIOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY;

EID: 70450263288     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2009.00914.x     Document Type: Article

References (15)

1. Dixon B, Santamaria J, Campbell D. Coagulation activation and organ dysfunction following cardiac surgery. Chest 2005 128 : 229 236.
2. Landis RC. Protease activated receptors: clinical relevance to hemostasis and inflammation. Hematol Oncol Clin North Am 2007 21 : 103 113.
3. Du XY, Zabel BA, Myles T, et al. Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets. J Biol Chem 2009 284 : 751 758.
4. Székely A, Cserép Z, Sápi E, et al. Risks and predictors of blood transfusion in pediatric patients undergoing open heart operations. Ann Thoracic Surg 2009 87 : 187 197.
5. Yeh T Jr., Kavarana MN. Cardiopulmonary bypass and the coagulation system. Prog Pediatr Cardiol 2005 21 : 87 115.
6. Wahba A, Videm V. Heart surgery with extracorporeal circulation leads to platelet activation at the time of hospital discharge. Eur J Cardiothorac Surg 2003 23 : 1046 1050.
7. McCall MM, Blackwell MM, Smyre JT, et al. Fresh frozen plasma in the pediatric pump prime: a prospective, randomized trial. Ann Thorac Surg 2004 77 : 983 987.
8. Oliver WC Jr., Beynen FM, Nuttall GA, et al. Blood loss in infants and children for open heart operations: albumin 5% versus fresh-frozen plasma in the prime. Ann Thorac Surg 2003 75 : 1506 1512.
9. Miller BE, Tosone SR, Guzzetta NA, et al. Fibrinogen in children undergoing cardiac surgery: is it effective? Anesth Analg 2004 99 : 1341 1346.
10. Karkouti K, Beattie WS, Arellano R, et al. Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. Circulation 2008 118 : 331 338.
11. Ranucci M, Isgrò G, Soro G, et al. Efficacy and safety of recombinant activated factor VII in major surgical procedures: systematic review and meta-analysis of randomized clinical trials. Arch Surg 2008 143 : 296 304.
12. Dietrich W, Spannagl M. Caveat against the use of recombinant factor VIIa for intractable bleeding in cardiac surgery (Letter). Anesth Analg 2002 94 : 1369 1370.
13. Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 2004 30 : 1873 1881.
14. Kierzkowska B, Stańczyk J, Wiectawska B, et al. Activation of circulating platelets and platelet response to activating agents in children with cyanotic congenital heart disease: their relevance to palliative systemic-pulmonary shunt. Int J Cardiol 2001 79 : 49 59.
15. Heying R, van Oeveren W, Wilhelm S, et al. Children undergoing cardiac surgery for complex cardiac defects show imbalance between pro- and anti-thrombotic activity. Crit Care 2006 10 : R165.